Royal Bank of Canada
KZIA

Royal Bank of Canada’s Kazia Therapeutics KZIA Stock Holding History

Royal Bank of Canada’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34,340
Closed -$255K – 7593
2026
Q1 		$255K Sell
34,340
-19,793
-37% -$138K ﹤0.01% 4559
2025
Q4 		$373K Buy
+54,133
New +$461K ﹤0.01% 4376
2022
Q3 		– Sell
-20
Closed -$4K – 7649
2022
Q2 		$4K Hold
20
– – ﹤0.01% 6730
2022
Q1 		$8K Buy
+20
New +$7.15K ﹤0.01% 7056
2021
Q4 		– Sell
-1
Closed -$1K – 7792
2021
Q3 		$1K Buy
+1
New +$491 ﹤0.01% 7480
2018
Q3 		– Sell
-25
Closed -$4K – 6829
2018
Q2 		$4K Hold
25
– – ﹤0.01% 6102
2018
Q1 		$7K Hold
25
– – ﹤0.01% 5833
2017
Q4 		$4K Hold
25
– – ﹤0.01% 6129
2017
Q3 		$4K Hold
25
– – ﹤0.01% 6461
2017
Q2 		$5K Hold
25
– – ﹤0.01% 6039
2017
Q1 		$7K Buy
25
+24
+2,400% +$7.56K ﹤0.01% 6102
2016
Q4 		$0 Buy
+1
New +$335 ﹤0.01% 6703
2016
Q2 		– Sell
-1
Closed – – 6451
2016
Q1 		$0 Buy
+1
New +$422 ﹤0.01% 6521
2015
Q3 		– Sell
-70
Closed -$56K – 6714
2015
Q2 		$56K Buy
+70
New +$79.4K ﹤0.01% 5163

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada's KZIA Position: Q2 2026 in Review

Royal Bank of Canada sold out of Kazia Therapeutics (KZIA) in Q2 2026, closing a stake of 34,340 shares — an estimated $255K sold.

Royal Bank of Canada first reported a position in KZIA in Q2 2015 and held it in 14 quarters. The position peaked at $373K in Q4 2025. 35 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Royal Bank of Canada reported no remaining Kazia Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 34,340 Kazia Therapeutics shares in Q2 2026, an estimated $255K.
  • Royal Bank of Canada first reported a position in Kazia Therapeutics in Q2 2015 and held it in 14 quarters.
  • Royal Bank of Canada's Kazia Therapeutics position peaked at $373K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.